Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Total 13F shares
-
5,151,654
-
Share change
-
-87,587
-
Total reported value
-
$15,299,000
-
Put/Call ratio
-
13%
-
Price per share
-
$2.97
-
Number of holders
-
39
-
Value change
-
-$457,844
-
Number of buys
-
21
-
Number of sells
-
20
Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q3 2022
As of 30 Sep 2022 PDS Biotechnology Corp - Common (PDSB) had 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,151,654 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, LPL Financial LLC, BlackRock Inc., TWO SIGMA ADVISERS, LP, RENAISSANCE TECHNOLOGIES LLC, INSPIRION WEALTH ADVISORS, LLC, TWO SIGMA INVESTMENTS, LP, FIRST MANHATTAN CO, GEODE CAPITAL MANAGEMENT, LLC, and Sofinnova Investments, Inc..
This table shows 39 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.